Sanfine International Hospital

date:2025-09-05

Sanfine International Hospital

Sanfine International Hospital: A “Health Hub” and “Benchmark for Full-Cycle Services” in International High-End Healthcare

Sanfine International Hospital is a Grade A tertiary general hospital approved by the National Health Commission. Jointly established by Sanfine Medical Group and overseas medical teams, it serves as an international high-end medical center integrating medical care, teaching, research, prevention, and rehabilitation. Located in the Wangjing Emerging Industry Zone of Beijing's Chaoyang District, adjacent to Wangjing SOHO and the International Medical Center, the hospital spans approximately 280,000 square meters. It offers over 1,200 beds and employs more than 1,800 staff members, including over 260 senior-level specialists, over 80 doctoral/master's advisors, and foreign experts constituting 15% of the workforce. Guided by its core principles of “international standards, precision medicine, and humanistic care,” the hospital specializes in precision oncology, cardiovascular and cerebrovascular diseases, neurodegenerative disorders, and premium health screening and rehabilitation. It also provides comprehensive services across all medical disciplines, including internal medicine, surgery, obstetrics and gynecology, and pediatrics, establishing an integrated full-cycle health service system encompassing “prevention-diagnosis-treatment-rehabilitation-prevention.” With annual outpatient visits exceeding 800,000 and surgical procedures surpassing 12,000, the hospital maintains internationally aligned technical standards in multidisciplinary tumor diagnosis and treatment (MDT), cardiovascular and cerebrovascular interventional therapies, neuromodulation technologies, and standardized international medical services. It serves as a “flagship institution” for China's high-end medical services and an “international cooperation demonstration base.”

I. Hospital Overview: China's International Healthcare Calling Card

Established through collaboration between Shengfang Medical Group, Johns Hopkins Hospital (USA), and the University of Tokyo School of Medicine (Japan), the hospital adopts the Joint Commission International (JCI) accreditation standards, fully aligning with global healthcare quality and safety management systems. It features four core disciplinary clusters: the Precision Oncology Center, Cardiovascular and Cerebrovascular Disease Center, Neurodegenerative Disease Center, and International Medical and Health Management Department, alongside supporting departments including General Practice, Emergency Medicine, Rehabilitation Medicine, and Radiology. It hosts national and international platforms such as the National Strategic Alliance for Minimally Invasive Cancer Treatment Technology Innovation, Beijing Key Laboratory of Precision Medicine, and International Medical Quality Certification Center. As a teaching hospital for Peking University Health Science Center and Capital Medical University, it cultivates hundreds of composite medical talents annually, equipped with ”global perspectives and clinical expertise." Guided by its mission to “enable global patients to access China's high-quality healthcare,” the hospital has established collaborations with medical institutions in over 30 countries through an “outbound + inbound” model. It annually treats more than 5,000 international patients, serving as a vital medical pillar in China's “Health Silk Road” initiative.

II. Technological Advantages: Full-Chain Innovation from “Precision Diagnosis and Treatment” to “International Standards”

With a focus on “resolving complex diseases” and “aligning with international frontiers,” the hospital has achieved breakthrough technologies across multiple domains:

• Precision Oncology: Globally Leading “Multi-Omics Testing + Personalized Therapy”

The Precision Oncology Center features internationally advanced Next-Generation Sequencing (NGS) platforms, circulating tumor DNA (ctDNA) detection systems, and AI-assisted diagnostics, enabling simultaneous detection of over 500 tumor driver genes and resistance mutations. Its innovative multidisciplinary approach combining “surgery + targeted therapy + immunotherapy + radiotherapy” has increased 5-year survival rates by 20% for common cancers like lung, breast, and colorectal cancers compared to traditional treatments. Cutting-edge therapies, including Tumor-Infiltrating Lymphocyte (TIL) Therapy and CAR-T Cell Therapy, achieve 45% objective response rates in advanced cancer patients.

• Cardiovascular and Cerebrovascular Diseases: “Interventional + Minimally Invasive + Smart Early Warning” Pushing Boundaries

The Cardiovascular and Cerebrovascular Disease Center specializes in treating complex coronary artery disease (left main lesions, chronic total occlusions), arrhythmias (atrial fibrillation, ventricular tachycardia), structural heart disease (aortic valve stenosis), and stroke (ischemic/hemorrhagic). It performs over 3,000 cardiac interventional procedures and 1,000 neurointerventional procedures annually. Through “FFR-guided precision stenting” and “one-stop AF radiofrequency ablation + LAA occlusion” procedures, stenting accuracy for coronary patients improved by 30%, while stroke risk for AF patients decreased by 60%. In stroke care, innovative “thrombolysis + thrombectomy” bridging therapy reduced door-to-needle time (DNT) to 25 minutes (world-leading), lowering disability rates from 35% to below 12%.

• Neurodegenerative Diseases: “Early Screening + Neuromodulation + Rehabilitation Intervention” redefines disease progression

The Center for Neurodegenerative Diseases focuses on Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurodegenerative disorders. It employs “cerebrospinal fluid Aβ/Tau protein testing + PET amyloid imaging + AI cognitive assessment” for early diagnosis, achieving 95% accuracy. Innovative integrated intervention combining “repetitive transcranial magnetic stimulation (rTMS) + deep brain stimulation (DBS) + cognitive training” slows cognitive decline by 50% in mild Alzheimer's patients and improves motor symptoms in 85% of Parkinson's patients. “Memory clinics + family care workshops” provide caregiving skills training to reduce family burdens.

• International Medical Services: “Standardized Processes + Customized Solutions” Deliver Warm, Thoughtful Care

The International Medical and Health Management Department adopted JCI accreditation standards, establishing a “Comprehensive Guide for International Patient Care” (including 20 detailed provisions such as language translation, medical record recognition, and direct insurance payment). Established a “Multidisciplinary International Consultation (MDT)” mechanism, collaborating with overseas experts to develop personalized treatment plans for complex cases; Equipped “International Medical Dedicated Wards” (including private rooms and family rooms), offering customized dietary options such as halal meals, vegetarian meals, and low-fat meals, while respecting patients' religious customs (e.g., Islamic prayer times, Christian holiday greetings).

III. Leading Specialties: A Core Discipline Matrix Covering Prevention, Diagnosis, Treatment, and Rehabilitation

The hospital boasts seven National Key Clinical Specialties (Precision Oncology, Cardiovascular Medicine, Neurosurgery, Emergency Medicine, Critical Care Medicine, Radiology, and Rehabilitation Medicine), including:

• Precision Oncology Department: A national key specialty treating over 4,000 cancer patients annually. It spearheaded the development of the Chinese Guidelines for Precision Cancer Diagnosis and Treatment and established a sister department partnership with MD Anderson Cancer Center in the United States, maintaining internationally advanced technical capabilities.

• Cardiovascular Medicine: A National Key Clinical Specialty with over 300,000 annual outpatient visits. Specializes in complex coronary artery disease and interventional treatment of arrhythmias, achieving a 98% success rate in Transcatheter Aortic Valve Implantation (TAVI).

• Neurosurgery: A National Key Specialty performing over 3,000 surgeries annually. Focuses on minimally invasive treatments for brain tumors (gliomas, meningiomas) and cerebrovascular diseases (aneurysms, arteriovenous malformations), reducing surgical disability rates from 25% to below 8%.

• International Medical and Health Management Department: A model international medical department serving over 5,000 international patients annually. JCI-accredited, it provides fully English-language services spanning “from outpatient care to rehabilitation.”

IV. Departmental Structure: Comprehensive Patient Care

Beyond core specialties, the hospital features:

• Department of General Practice (offering “primary care responsibility + two-way referral” services)

• Department of Respiratory and Critical Care Medicine (specializing in COPD and precision lung cancer diagnosis/treatment)

• Department of Gastroenterology (early gastrointestinal cancer screening, endoscopic therapies)

• Department of Orthopedics (spinal degenerative disorders, joint replacement) Obstetrics and Gynecology (high-risk pregnancy management, minimally invasive gynecologic oncology surgery), Pediatrics (diagnosis and treatment of pediatric neurodevelopmental disorders), Ophthalmology (glaucoma, cataracts), Otolaryngology (hearing loss, tinnitus, vertigo), Dentistry (high-end dental implants, pediatric oral prevention), Dermatology (diagnosis and treatment of complex skin diseases), Traditional Chinese Medicine Department (integrated Chinese and Western medicine regulation), Nutrition (lifecycle nutrition management), Laboratory (precision medicine testing), Radiology (AI-assisted imaging diagnosis), Pathology (molecular pathology diagnosis), and over 40 other clinical departments. Supported by auxiliary units including the Telemedicine Center (connecting over 50 global medical institutions) and Health Management Center (premium health screenings and risk assessment), we deliver an integrated “prevention-diagnosis-treatment-rehabilitation” service network.

V. Medical Equipment: World-Class Devices Empowering Precision Diagnostics

The hospital is equipped with globally leading medical devices to support complex and critical care:

• Oncology Equipment: Varian TrueBeam Linear Accelerator (high-precision radiotherapy), Siemens PET-MR (early tumor screening), Illumina NextSeq 550 Sequencer (tumor driver gene testing).

• Cardiovascular and Cerebrovascular Equipment:

• Cardiovascular and Cereb

• Neurodegenerative Disease Equipment: Echosens FibroScan 502 (non-invasive liver fibrosis diagnosis), RehaCom Cognitive Rehabilitation System (AD, Parkinson's cognitive impairment treatment), NeuroScan EEG Evoked Potential System (epileptic focus localization).

• Surgical Robots: Intuitive Surgical (USA) Da Vinci Xi Surgical Robot (minimally invasive surgery for oncology and urology), domestically produced neurosurgical robot (precise localization for brain tumors).

VI. International Patient Services: Global Healthcare with a “Chinese Touch”

As a “Designated Foreign Medical Service Provider by the National Health Commission” and a “JCI-Accredited Hospital,” our institution serves as a key referral destination for patients from Europe, America, Southeast Asia, the Middle East, and beyond. We provide comprehensive, seamless services for international patients:

• Multilingual Support: Our International Medical Department employs professional translators fluent in over 10 languages, including English, French, Spanish, Japanese, and Arabic. Medical staff maintain basic foreign language communication skills. Critical examination reports (e.g., imaging, pathology) are provided in bilingual Chinese-English versions.

• One-Stop Services: Assistance with registration, test scheduling, medical record translation, visa extensions, and other procedures. Priority access (emergency patients seen within 30 minutes) with dedicated patient navigators.

• International Insurance Coverage: Partnerships with MSH (Wanxinhe), Cigna, Aetna, and other global insurers for direct billing support. Enables international credit card and cross-border payment (Alipay/WeChat Pay) services.

• Cultural Adaptation Services: Patient rooms offer internationally compliant meals (e.g., halal, vegetarian, low-salt/low-fat options); respect religious customs (e.g., Islamic prayer times, Christian holiday greetings); provide dedicated religious activity rooms and psychological counseling specialists (addressing cross-cultural adaptation anxiety).

• Telemedicine: Collaborations established with Johns Hopkins Hospital (USA), King's College Hospital (UK), and Tokyo University Hospital (Japan) enable video-linked international expert consultations for complex cases.

VII. International Patient Testimonials: “Professional Healing, Warmth Beyond Borders”

• Emily (52, breast cancer, USA): “After my breast cancer diagnosis in the US, doctors recommended chemotherapy plus surgery. At Shengfang, the Tumor Center detected a HER2 mutation via NGS testing and tailored a ‘targeted therapy + breast-conserving surgery + radiotherapy’ plan. My tumor markers are now normal! Nurses patiently explained each treatment step in English, easing my fears.”

• Japanese Patient Yuki (68, Alzheimer's Disease): “Diagnosed with moderate Alzheimer's in Japan, my family couldn't care for me. Shengfang International's Neurodegenerative Disease Center used a ‘cognitive training + medication adjustment’ plan. After 3 months, I could recognize my family! Nurses taught my family memory games, and now I'm much better.”

• Indonesian Patient Siti (45, Acute Myocardial Infarction): “I suffered a sudden heart attack in Indonesia, and the local hospital recommended transfer. Sanfine's emergency green channel performed my stent surgery within 20 minutes. Post-op ECMO support lasted 12 hours, and my cardiac function has recovered remarkably well. The doctor explained every risk step by step in English, which was very reassuring.”

VIII. Contact Information & Transportation Guide

• Hospital Address: No. 2 Qiyang Road, Wangjing, Chaoyang District, Beijing (Sanfine International Hospital Main Campus).

• Consultation Hotline: 010-84108800 (Main Switchboard), 010-84108120 (International Patient Service Line).

• WeChat Official Account: Search “Sanfine International Hospital Service Account” for online appointments, report inquiries, and health education resources.

• Transportation Routes:

• Subway: Exit C at Wangjing Station (Line 15), 10-minute walk;

• Bus: Take routes 421, 471, 594, etc., and get off at “Wangjing Hospital Station”;

• Driving: The hospital has an underground parking garage (rate: ¥8/hour). Nearby parking is available at Wangjing SOHO (5-minute walk).

Sanfine International Hospital, guided by its mission of “International Standards, Heartfelt Service,” has consistently served as a trusted “health hub” for patients. Leveraging its deep expertise in precision oncology, cardiovascular and cerebrovascular diseases, and innovative international medical practices, the hospital delivers high-quality, compassionate care. Whether providing standardized treatment for common conditions or tackling complex cases through multidisciplinary collaboration, Sanfine combines “Chinese wisdom” with a “global perspective” to offer patients exceptional medical services.

Document dated 2025-09-15 15:11 Modify